(Q30910692)

27 June 2017

1 reference

title

Aventis Pasteur vaccines containing inactivated hepatitis A virus: a compilation of immunogenicity data (English)

1 reference

27 June 2017

1 reference

1 reference

Vidor E

1

1 reference

27 June 2017

Dumas R

2

1 reference

27 June 2017

Porteret V

3

1 reference

27 June 2017

Bailleux F

4

1 reference

27 June 2017

Veitch K

5

1 reference

27 June 2017

publication date

6 March 2004

1 reference

European Journal of Clinical Microbiology & Infectious Diseases

27 June 2017

published in

1 reference

27 June 2017

volume

23

1 reference

27 June 2017

issue

4

1 reference

27 June 2017

page(s)

300-309

1 reference

Depression of the immune response to an inactivated hepatitis A vaccine administered concomitantly with immune globulin.

27 June 2017

cites work

1 reference

12 December 2020

Good immunogenicity of GBM strain inactivated hepatitis A vaccine in healthy male adults

1 reference

12 December 2020

Immunogenicity and safety of two doses of a paediatric hepatitis A vaccine in thai children: comparison of three vaccination schedules

1 reference

12 December 2020

Inactivated hepatitis A vaccine booster given >/=24 months after the primary dose

1 reference

12 December 2020

Clinical development of a new inactivated hepatitis A vaccine

1 reference

12 December 2020

Does immunoglobulin interfere with the immunogenicity to Pasteur Mérieux inactivated hepatitis A vaccine?

1 reference

12 December 2020

Inadequate response to intradermal hepatitis A vaccine

1 reference

12 December 2020

Simultaneous passive and active immunization against hepatitis A

1 reference

12 December 2020

Hepatitis A vaccine: immunogenicity following administration of a delayed immunization schedule in infants, children and adults.

1 reference

12 December 2020

Immunization against hepatitis A in the first year of life: priming despite the presence of maternal antibody

1 reference

12 December 2020

Development of the formalin-inactivated hepatitis A vaccine, VAQTA from the live attenuated virus strain CR326F.

1 reference

12 December 2020

Long-term immunogenicity of an inactivated virosome hepatitis A vaccine.

1 reference

12 December 2020

Long-term persistence of anti-HAV antibodies following active immunization with hepatitis A vaccine

1 reference

12 December 2020

Duration of protection from clinical hepatitis A disease after vaccination with VAQTA.

1 reference

12 December 2020

Immunogenicity and safety of a new inactivated hepatitis A vaccine: a clinical trial with comparison of administration route

1 reference

12 December 2020

Immunoglobulin prophylaxis for hepatitis A

1 reference

12 December 2020

Clinical and immunological investigation of a new combined hepatitis A and hepatitis B vaccine

1 reference

12 December 2020

Hepatitis A booster vaccine in children after infant immunization

1 reference

12 December 2020

Comparison of immunogenicity of two hepatitis A vaccines--VAQTA and HAVRIX--in young adults.

1 reference

12 December 2020

Clinical trial to evaluate immunogenicity and safety of inactivated hepatitis A vaccination starting at 2-month-old children

1 reference

12 December 2020

Comparison of two immunization schedules with an inactivated hepatitis A vaccine (AvaximTM).

1 reference

12 December 2020

Safety and immunogenicity of a new inactivated hepatitis A vaccine in concurrent administration with a typhoid fever vaccine or a typhoid fever + yellow fever vaccine

1 reference

12 December 2020

Worldwide experience with the CR326F-derived inactivated hepatitis A virus vaccine in pediatric and adult populations: an overview

1 reference

12 December 2020

Persistence of antibodies after inactivated hepatitis A vaccines in a comparative study

1 reference

12 December 2020

Immunogenicity and protectivity of a new liposomal hepatitis A vaccine

1 reference

12 December 2020

A combined dual-chamber typhoid/hepatitis A vaccine as a booster dose in hepatitis A primed adults

1 reference

12 December 2020

A randomized study of a flexible booster dosing regimen of VAQTA in adults: safety, tolerability, and immunogenicity

1 reference

12 December 2020

Exposure of Indian children to hepatitis A virus & vaccination age.

1 reference

12 December 2020

Immunogenicity and safety of a new inactivated hepatitis A vaccine in a comparative study

1 reference

12 December 2020

Estimated persistence of anti-HAV antibodies after single dose and booster hepatitis A vaccination (0-6 schedule).

1 reference

12 December 2020

Immunogenicity and reactogenicity of Avaxim (160 AU) as compared with Havrix (1440 EL.U) as a booster following primary immunization with Havrix (1440 EL.U) against hepatitis A

1 reference

12 December 2020

Immunogenicity and safety of a new inactivated hepatitis A vaccine in Thai young adults.

1 reference

12 December 2020

Excellent booster response 4-6 y after a single primary dose of an inactivated hepatitis A vaccine.

1 reference

12 December 2020

Safety and immunogenicity of a new formulation of an inactivated hepatitis A vaccine.

1 reference

12 December 2020

Analysis of the antibody response in humans with a new inactivated hepatitis A vaccine.

1 reference

12 December 2020

Safety and immunogenicity of a pediatric formulation of inactivated hepatitis A vaccine in Argentinean children

1 reference

12 December 2020

Hepatitis A vaccine administration: comparison between jet-injector and needle injection

1 reference

12 December 2020

Hepatitis A virus-specific humoral and cellular immune responses following immunization with a formalin-inactivated hepatitis A vaccine

1 reference

12 December 2020

Hepatitis A antibody titres after infection and immunization: implications for passive and active immunization

1 reference

12 December 2020

Mathematical models for assessment of long-term persistence of antibodies after vaccination with two inactivated hepatitis A vaccines.

1 reference

12 December 2020

The effect of age and weight on the response to formalin inactivated, alum-adjuvanted hepatitis A vaccine in healthy adults

1 reference

12 December 2020

Comparison of two combined vaccines against typhoid fever and hepatitis A in healthy adults

1 reference

12 December 2020

Prevention of hepatitis A through active or passive immunization: Recommendations of the Advisory Committee on Immunization Practices (ACIP)

1 reference

12 December 2020

Tolerance and immunogenicity of the simultaneous administration of virosome hepatitis A and yellow fever vaccines

1 reference

12 December 2020

Immunopotentiating reconstituted influenza virus virosome vaccine delivery system for immunization against hepatitis A

1 reference

12 December 2020

Randomized, cross-over, controlled comparison of two inactivated hepatitis A vaccines

1 reference

12 December 2020

Immunization of seronegative infants with hepatitis A vaccine (HAVRIX; SKB): a comparative study of two dosing schedules

1 reference

12 December 2020

Immunological priming of one dose of inactivated hepatitis A vaccine given during the first year of life in presence of maternal antibodies

1 reference

12 December 2020

Inactivated hepatitis A vaccine-induced antibodies: follow-up and estimates of long-term persistence.

1 reference

12 December 2020

Safety and immunogenicity of hepatitis A vaccine in infants: a candidate for inclusion in the childhood vaccination programme

1 reference

12 December 2020

An open study of subcutaneous administration of inactivated hepatitis A vaccine (VAQTA) in adults: safety, tolerability, and immunogenicity

1 reference

12 December 2020

Production, quality control and characterization of an inactivated hepatitis A vaccine

1 reference

12 December 2020

Inactivated hepatitis A vaccine: reactogenicity, immunogenicity, and long-term antibody persistence

1 reference

12 December 2020

Concurrent administration of inactivated hepatitis A vaccine with immune globulin in healthy adults

1 reference

12 December 2020

A randomised comparison of two inactivated hepatitis A vaccines, Avaxim and Vaqta, given as a booster to subjects primed with Avaxim

1 reference

12 December 2020

Effect of virus strain and antigen dose on immunogenicity and reactogenicity of an inactivated hepatitis A vaccine

1 reference

12 December 2020

Six years' follow-up after hepatitis A vaccination

1 reference

12 December 2020

Comparative immunogenicity and tolerance of Vaqta and Havrix

1 reference

12 December 2020

Clinical assessment of the safety and efficacy of an inactivated hepatitis A vaccine: rationale and summary of findings

1 reference

12 December 2020

Immunogenicity and safety of an inactivated hepatitis A vaccine in Taiwanese adults and children

1 reference

12 December 2020

Simultaneous active and passive immunization against hepatitis A studied in a population of travellers

1 reference

12 December 2020

10.1007/S10096-003-1094-0

Identifiers

DOI

1 reference

Dimensions Publication ID

27 June 2017

1011875266

0 references

1 reference